4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
NRx Pharmaceuticals, Inc. (NRXP) operates in the Biotechnology industry and is headquartered in Wilmington, United States with about 29 employees. Its market capitalization is roughly $179 million. In the fiscal year ended 2025-12-31, NRXP reported $1M in revenue and ($29M) in net income.
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments.
Interactive charts & full statements → Open the NRXP valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1M | $0M | $0M | $0M | — |
| Gross Profit | $1M | $0M | — | — | — |
| Operating Income (EBIT) | ($16M) | ($18M) | ($28M) | ($44M) | — |
| Net Income | ($29M) | ($25M) | ($30M) | ($40M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $1M | $1M | $0M | $0M | $0M | — |
| Gross Profit | $0M | $1M | $0M | — | $0M | — |
| Operating Income (EBIT) | ($5M) | ($5M) | ($4M) | ($4M) | ($4M) | — |
| Net Income | ($1M) | $0M | ($6M) | ($18M) | ($6M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $13M | $4M | $7M | $26M | — |
| Total Liabilities | $29M | $27M | $19M | $18M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NRXP viewer.
About TickerBase · Data methodology & sources